Next on tap for Meridian Bioscience‘s (NASDAQ:VIVO) illumigene molecular diagnostic testing platform is a test for Mycoplasma pneumonia, an infection of the lungs. The illumigene Mycoplasma test is ...
Indications : Culture isolation of M. pneumoniae is a tedious and laborious process. Diagnosis through molecular methods is specific and sensitive and is hence the preferred method to detect this ...
LONDON--(BUSINESS WIRE)--The global mycoplasma testing market size is expected to grow by USD 445.57 million as per Technavio. This marks a significant market growth compared to the 2019 growth ...
Eurofins Lancaster Laboratories has launched a new validated Rapid Mycoplasma Detection Test, overcoming time-consuming challenges of the standard 28-day compendial method for mycoplasma testing. For ...
Mycoplasma contamination of manufacturing cell cultures is rare, but presents a threat for biologics manufacturers. Traditionally, testing was done using a culture-based, 28-day mycoplasma test. More ...
Global Mycoplasma Testing in Clinical Market business report is a wonderful guide to achieve an information or key data about market, emerging trends, product usage, motivating factors for customers, ...
Roche's MycoTOOL, which offers rapid detection of mycoplasms based on a polymerase chain reaction (PCR) test, has received FDA acceptance. Mycoplasma contamination is a common and significant issue in ...
LONDON--(BUSINESS WIRE)--Technavio market research analysts have predicted the global mycoplasma testing market to grow at a CAGR of more than 11% during the period 2018-2022, according to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results